Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Michael C. Paul-Smith"'
Autor:
Kamila M Pytel, Jean-François Gélinas, Deborah R. Gill, Lee A. Davies, Amit C. Nathwani, Stephen C. Hyde, Lidia Cammack, Makoto Inoue, Ian A. Pringle, Caroline Moran, Eric W.F.W. Alton, S Tsugumine, Michael C. Paul-Smith, Mario Chan, Takashi Hironaka, Loren Cameron, Cuixiang Meng, Uta Griesenbach, Jenny McIntosh, Robyn V. Bell
Publikováno v:
Gene Therapy
We have shown that a lentiviral vector (rSIV.F/HN) pseudotyped with the F and HN proteins from Sendai virus generates high levels of intracellular proteins after lung transduction. Here, we evaluate the use of rSIV.F/HN for production of secreted pro
Introduction: Since identification of the disease causing gene over 25 years ago, cystic fibrosis (CF) has been at the forefront of gene therapy research. Despite initial optimism, CF gene therapy has proven considerably more challenging than initial
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::762a211af48e785c281409a87a3d6819
http://hdl.handle.net/10044/1/32253
http://hdl.handle.net/10044/1/32253
Autor:
Deborah R. Gill, Amit C. Nathwani, Stephen C. Hyde, Uta Griesenbach, Kamila M Pytel, Cuixiang Meng, Jenny McIntosh, Lee A. Davies, Ian A. Pringle, Mario Chan, Michael C. Paul-Smith, Mamoru Hasegawa, Eric W.F.W. Alton, Makoto Inoue
Publikováno v:
Molecular Therapy. 23
We have previously shown that the lung can be used as “factory” for production of secreted proteins, which are released into the circulation, using Sendai virus-mediated gene transfer. However, gene expression was transient and repeated administr
Autor:
C Meng, Stephen C. Hyde, Ewfw Alton, Kamila M Pytel, Mamoru Hasegawa, U Griesenbach, Jean-François Gélinas, Lee A. Davies, L Cameron, L Cammack, C Moran, Mario Chan, Gill, Makoto Inoue, Michael C. Paul-Smith, Ian A. Pringle
Publikováno v:
Thorax. 70:A72-A73
Introduction and objectives A protease/anti-protease imbalance is a characteristic feature of inflammatory lung diseases such as cystic fibrosis (CF) and alpha-1-antitrypsin deficiency related emphysema. A recent trial of alpha-1-antitrypsin (hAAT) e
Autor:
C Moran, Ewfw Alton, S Tsugumine, T Higgins, Ian A. Pringle, U Griesenbach, Lee A. Davies, S C Hyde, Andrea Rodriguez-Martinez, Jane C. Davies, Barbara J Stevenson, Kamila M Pytel, Sabrina Gea-Sorli, Laura Hyndman, Gill, Amanda Boyd, Mamoru Hasegawa, Makoto Inoue, Johanna F. Dekkers, Heather E Davidson, G McLachlan, Michael C. Paul-Smith, C Meng, Jeffrey M. Beekman, Mario Chan
Publikováno v:
Thorax. 70:A34.2-A34
The UK CF Gene Therapy Consortium has developed a pipeline of vectors to deliver CFTR into the airway epithelium. The first of these (plasmid/liposome complexes) recently completed a Phase IIb trial. Anticipating that increased efficiency of gene tra
Autor:
Ian A. Pringle, Amit C. Nathwani, Gill, Jenny McIntosh, Ewfw Alton, Mario Chan, Kamila M Pytel, Michael C. Paul-Smith, Makoto Inoue, L Davis, Cuixiang Meng, Mamoru Hasegawa, Uta Griesenbach, Stephen C. Hyde
Publikováno v:
Thorax. 70:A67.1-A67
We have previously shown that lung when treated with Sendai virus-mediated gene transfer can produce secreted proteins and release them into the circulation (Griesenbach et al. , Mol Therapy 2002). Despite the high levels of transduction efficiency t
Autor:
Caroline Moran, Mamoru Hasegawa, Michael C. Paul-Smith, Ian A. Pringle, Uta Griesenbach, Kamila M Pytel, Stephen C. Hyde, Cuixang Meng, Loren Cameron, Eric W.F.W. Alton, Makoto Inoue, Lee A. Davies, Deborah R. Gill, Lidia Cammack, Jean-François Gélinas, Mario Chan
Publikováno v:
Molecular Therapy. 23:S147
A protease/anti-protease imbalance is a characteristic feature of inflammatory lung diseases such as cystic fibrosis (CF) and chronic obstructive pulmonary disease (COPD). However, alpha-1-antitrypsin (AAT) enzyme replacement therapy (ERT) trials hav